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INTRODUCTION
Preeclampsia as one of the most devastating obs-
tetric problems is still not solved completely. Pree-
clampsia was occurred in approximately 1.8 to
16.7% of pregnancies, whereas the incidence of
preeclampsia was varied among countries.1 Based
on the systematic review conducted by the WHO,
about 16% of maternal deaths in developed coun-
tries, including the United States, were caused by
hypertension in pregnancy and its complications.
This complication passed through other major
causes, such as bleeding (13%), abortion (8%), and
sepsis (2%).2 In Indonesia itself, the average inci-
dence of preeclampsia was 3-10% and the mater-
nal mortality rate (MMR) was approximately
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Objective: To understand the relationship of heme oxygenase-1
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features.
[Indones J Obstet Gynecol 2016; 4-3: 128-132]
Keywords: heme oxygenase-1 (HO-1), normotensive pregnancy,
preeclampsia with severe features
Abstrak
Tujuan: Untuk memahami hubungan kadar heme oxygenase-1 (HO-
1) pada kehamilan normotensi dan preeklamsia dengan karakteristikperburukan.
Metode: Penelitian ini merupakan studi potong lintang. Penelitian inidilaksanakan di Bagian Obstetri dan Ginekologi FK Universitas Sam
Ratulangi/BLU RSUP Prof. Dr. R. D. Kandou Manado. Subjek penelitian
terdiri dari 26 pasien dengan kehamilan normotensi dan 26 pasiendengan kehamilan preeklamsia dengan karakteristik perburukan. Di-
lakukan anamnesis, pemeriksaan fisik umum dan kemudian dicatatdalam status penelitian, kemudian perempuan dengan kehamilan
normotensi >20 minggu dan perempuan hamil >20 minggu dengan
preeklamsia dengan karakteristik perburukan diambil sampel darahdan dibawa ke laboratorium. Data yang diperoleh diolah dengan kom-
puter menggunakan perangkat lunak program SPSS 20,0. Uji non
parametric Mann-Whitney digunakan untuk menganalisa hubunganantara kadar HO-1 pada kehamilan normotensi dan preeklamsia
berat.
Hasil: Pasien hamil normotensi memiliki kadar HO-1 sebesar 3,24 (SD
0,58) ng/ml (95% IK 3,00-3,47), pasien hamil preeklamsia dengankarakteristik perburukan memiliki kadar HO-1 sebesar 3,92 (SD 0,73)
ng/ml (95% IK 3,62-4,21). Uji Mann-Whitney menunjukkan bahwa
p=0,001 yang berarti bahwa terdapat perbedaan bermakna kadarheme oxygenase-1 (HO-1) pada pasien normotensi dan preeklamsia
dengan karakteristik perburukan.
Kesimpulan: Terdapat hubungan bermakna antara kadar HO-1 de-
ngan kejadian preeklamsia dengan karakteristik perburukan.
[Maj Obstet Ginekol Indones 2016; 4-3: 128-132]
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4.91%, ranging from 8,739 to 170,725 deaths.3
Several factors have been associated with the inci-
dence of preeclampsia. In general, these risk fac-
tors can be classified as maternal factors (extreme
age, parity, history of preeclampsia), medical risk
factors (chronic hypertension, diabetes mellitus or
renal disease) and factors of the placenta (hyper-
placentosis on twin pregnancy and gestational tro-
phoblastic diseases). Nevertheless, these predis-
posing factors cannot be explained with clear pa-
thogenesis.4
In addition to the dominance of several risk fac-
tors, a lot of theories have been developed to ex-
plain the pathogenesis of preeclampsia, including
genetic, immunological, oxidative stress, inflamma-
tion, hypoxia, angiogenic, and hormonal factors.
Many theories tend to agree that the initial pro-
blem is the disruption of trophoblastic invasion,
unfortunately, there are still no theories with sa-
tisfactory answers which correlating among each
factors to the complication of preeclampsia.
In recent years, various evidences show that
heme oxygenase-1 (HO-1) is very important in
pregnancy. Therefore, we need to understand the
mechanisms underlying the protective effect of HO-
1. These mechanisms can be varied depending on
the reproductive phase of the HO-1 involvement.
The microenvironment in which HO-1 performs its
action also greatly affects the protective mecha-
nisms. Study on the mechanisms underlying the
emergence of HO-1 effects to the process of preg-
nancy is through the release of CO by HO-1. This
process not only occurs in the reproductive pro-
cess,5,6 but also in several inflammatory pro-
cesses.7,8 This study aims to understand the rela-
tionship of HO-1 level between normotensive preg-
nancy and preeclampsia with severe features.
METHODS
This was a cross sectional study which conducted
at the Department of Obstetrics and Gynecology,
Faculty of Medicine, Universitas Sam Ratulangi/
Prof. Dr. R. D. Kandou General Hospital Manado,
from March 1st to May 31st 2015. The inclusion cri-
teria include pregnant women with more than 20
weeks of gestational age, having normal blood
pressure or preeclampsia with severe features,
they would like to fill the informed consent and
participate in the study. Meanwhile, the exclusion
criteria consist of pregnant women with diabetes
mellitus, kidney disorders, heart diseases, chronic
hypertension, premature rupture of membranes
(PROM), clinical signs of infection, multiple preg-
nancy, in utero fetal death (IUFD), and also not
willing to participate in this study. The data was
processed by computer using SPSS 20.0 software.
Non parametric Mann-Whitney test was used to
analyze the relationship between the level of HO-1
in normotensive pregnancy and preeclampsia with
severe features.
Table 1. Characteristics of Subjects
Characteristics
Normal Blood Pressure Preeclampsia with Severe Features
N % N %
Parity
Primiparous 9 34.61 8 30.76
Multiparous 17 65.38 18 69.23
Gestational Age
20-28 week 6 23.07 6 23.07
29-36 week 10 38.46 10 38.46
 37 week 10 38.46 10 38.46
Education
Elementary 1 3.84 4 15.38
Junior high school 2 7.69 3 11.53
Senior high school 23 88.46 15 57.69
University 0 0 4 15.38
Occupation
Housewife 18 69.23 17 65.38
Student 3 11.53 1 3.84
Private company employee 5 19.23 4 15.38
Government employee 0 0 4 15.38
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RESULTS
We got 26 pregnant women with normal blood
pressure and the other 26 women with preeclamp-
sia with severe features. Based on the data pre-
sented in Table 1, most of the subjects are multi-
parous (65.38% in normotensive pregnancy and
69.23% in preeclampsia with severe features). The
subjects with 29-36 weeks and 37 weeks of ges-
tational age had the same percentage between wo-
men with normal blood pressure and preeclampsia
with severe features (38.46% for each). Most of
them were graduated from senior high school
(88.46% in normotensive pregnancy and 57.69%
in preeclampsia with severe features) and they
worked as housewives (69.23% in normotensive
pregnancy and 65.38% in preeclampsia with se-
vere features).
Table 2 depicted the differences of HO-1 level in
normotensive pregnancy and preeclampsia with
severe features women. Of 26 samples in normo-
tensive pregnancy, the average level of HO-1 was
at 3.24 ng/ml (95% CI 3.00-3.48), with a standard
deviation of 0.58 ng/ml. Meanwhile, of 26 samples
in preeclampsia with severe features, the average
value of HO-1 level was 3.92 ng/ml (95% CI 3.62-
4.21), with a standard deviation of 0.73 ng/ml. The
statistical analysis described there was significant
relationship between the levels of HO-1 and the in-
cidence of preeclampsia with severe features.
DISCUSSION
This study showed that the level of HO-1 in mater-
nal serum during pregnancy were significantly
higher in preeclampsia women with severe fea-
tures compared with normal blood pressure wo-
men. Further more, this study showed a positive
correlation between the levels of serum HO-1 and
the severity of preeclampsia.
Actually, heme oxygenase is an important
enzyme system in the human body. There are three
isoforms of heme oxygenase, consisting of indu-
cible HO-1, constitutive HO-2, and HO-3 which
function are still unknown.9 The importance of this
enzyme and its catalytic product in the mainte-
nance of normal pregnancy to term has recently
been disclosed. Heme oxygenase catalyzes the oxi-
dation of heme into carbon monoxide (CO), biliver-
din, and iron, as well as it has a key role in tissue
protection against oxidative stress.10 Today, it is
clearly understood that the HO-CO-biliverdin sys-
tem is involved in the formation of normal placenta
and in the hemodynamic control of placenta and
fetal tissues. Heme oxygenase system regulation in
the placenta is a complex process and it partly de-
pends on the local concentration of glucose and
oxygen.11,12
Some studies found a decrease in the expression
and/or activity of HO-1 in human placenta in preg-
nancy or in individuals with hypertensive disor-
ders;9 while, other studies reported a decrease oc-
curred only in the level of HO-2 and not in the level
of HO-1.13,14 Several other studies had shown that
there was no difference of HO-1 protein level bet-
ween pregnancies with mild preeclampsia and un-
complicated pregnancy.10 However, all these stu-
dies were conducted on the levels of HO in the pla-
centa, and only few data were available regarding
the changes in maternal serum of HO-1 level in
normal pregnancies and pregnancies complicated
by preeclampsia. Our results showed that HO-1
level was increased in plasma of preeclampsia wo-
men with severe features compared with women
with normal blood pressure. There were only two
studies conducted by Eide, et al. and Vitoratos, et
al. which resulted similar to our study. They found
the increased level of HO-1 in serum and decidual
tissue, accompanied by changes in the expression
Table 2. Descriptive Analysis of the Heme Oxygenase-1 (HO-1) Level Differences between Normotensive Pregnancy and
     Preeclampsia with Severe Features.
Study Variables Normal Blood Pressure Preeclampsia with SevereFeatures p
Heme oxygenase-1 (HO-1)
Mean 3.2388 3.9154 0.001
95% Confidence Interval 3.00 - 3.48 3.62 - 4.21
Minimum 2.41 2.88
Maximum 4.39 5.67
Standard Deviation 0.58 0.73
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of the decidua. This result supported the role of
these substances in oxidative stress and excessive
inflammatory responses in the pathogenesis of ma-
ternal preeclampsia.15,16
Reactive oxygen species (ROS) will be seques-
tered by antioxidants, which may have non-struc-
tural proteins, such as vitamin E, C and A, as well
as by metabolites, such as glutathione, ubiquinone
and uric acid. Antioxidants based protein include
catalase, heme oxygenase, glutathione peroxidase
and thioredoxin peroxidase.17 Normal pregnancies
are characterized by a transient increase ROS pro-
duction which neutralized by the induction of an-
tioxidant defense mechanisms.18 Preeclampsia is
associated with the increased of oxidative stress
not only in the placenta, but also scattered in the
maternal circulation. It is thought to be part of a
systemic inflammatory response.19,20 Increased
oxidative stress occurs as a result of excessive ROS
production or due to interference in antioxidant ca-
pacity;17 however, oxidative stress is closely re-
lated to the severity of preeclampsia clinically.21
Heme oxygenase-1 enzyme experiences rapid up-
regulation through oxidative stress and the induc-
tion of HO-1 may protect the cells through binding
metaloporphyrin catalyze pro-oxidants, such as
heme, bile pigments (biliverdin, bilirubin) that has
function as free radicals.22 We found an increased
serum HO-1 in preeclampsia with severe features
compared with normal blood pressure group. Pre-
vious report showed that the level of oxygen radi-
cal absorbance based on the direct neutralization
of free radicals was unchanged in women with mild
preeclampsia.23
In contrast, free irons and particularly carbon
monoxide are produced from HO-1 which is me-
diated by heme catabolism.24 Previous study ex-
plained an increase of serum iron and carboxy-
hemoglobin concentration in preeclampsia, which
reflected the raising of heme and erythrocyte turn-
over; also it demonstrated that this endogenous
production could change the maternal and fetal
oxygenation.25 Thus, there might be a potential link
between HO-1 and the severity of preeclampsia. In-
deed, based on our results, the serum level of HO-1
seemed to be related to the severity of the disease
in preeclamptic women with severe features. Al-
though in those study the serum levels of HO-1
were positively correlated with both the overall
study population and in women with preeclampsia,
we could not describe the correlation in control
group. Vitoratos, et al. through their study showed
that the increased activity of HO-1 serum in severe
preeclampsia would persist long after childbirth. It
explained the key role of persistent oxidative
stress, the increased vascular resistance, and the
chronic excessive maternal inflammatory response
in the pathophysiology of preeclampsia.16 There-
fore, further clinical trial with larger samples and
repeated measurement during pregnancy is re-
quired to properly evaluate the exact role of HO-1
both in normal pregnancy and preeclampsia.
There are several limitations to our study. The
limited number of patients could reduce the
strength of this study and in creased the chances
of error. As a result, a significant correlation might
be missed. The measurement of HO-1 level was
only performed once during pregnancy. It would
be more accurate if the repeated measurement of
maternal serum HO-1 level was performed every
week to allow a better assessment of the temporal
changes and explain the further interaction.
CONCLUSION
This study assesses the level of maternal serum
HO-1 in preeclampsia with severe features as well
as in normal pregnancy. Increased level of HO-1 is
found in preeclampsia with severe features
compared with normal pregnancy, reflecting the
significant correlation between HO-1 level and the
severity of preeclampsia.
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